Future Ink: The Collision of AI and Chinese Calligraphy
Journal on Computing and Cultural Heritage · 31.03.2025 · 18 (1) · 1-17
DOI: 10.1145/3700882 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal on Computing and Cultural Heritage, online erschienen am 17.02.2025. Verfasst von Troy TianYu Lin und 3 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
This survey delves deeply into the application, limitations, and opportunities of AI technology within the realm of Chinese calligraphy. It examines AI’s role in assessing calligraphic aesthetics, the automatic generation of artworks, style recognition, and robotic calligraphy, while addressing the capabilities and constraints of current AI algorithms and tools in the creation of Chinese calligraphy. Furthermore, it investigates the potential for AI to foster innovation and global heritage in the art of calligraphy, showcasing the potential and prospects for integrating AI with traditional Chinese calligraphy. The aim is to highlight the significance of AI in the preservation and innovation of traditional Chinese calligraphic art, to encourage interdisciplinary dialogue and collaboration between art and technology, and to offer new perspectives and approaches for the future development of calligraphy.
Zitieren
APA
Lin, T. T., She, J., Wang, Y., & Zhang, K. (2025). Future Ink: The Collision of AI and Chinese Calligraphy. Journal on Computing and Cultural Heritage, 18(1), 1-17. https://doi.org/10.1145/3700882
Vancouver
Lin TT, She J, Wang Y, Zhang K. Future Ink: The Collision of AI and Chinese Calligraphy. Journal on Computing and Cultural Heritage. 2025;18(1):1-17. doi:10.1145/3700882
BibTeX
@article{Lin2025,
author = {Lin, Troy TianYu and She, James and Wang, Yu-Ao and Zhang, Kang},
title = {Future Ink: The Collision of AI and Chinese Calligraphy},
journal = {Journal on Computing and Cultural Heritage},
year = {2025},
volume = {18},
number = {1},
pages = {1--17},
doi = {10.1145/3700882}
}
EUVIMED